Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The phase 3 TRIUMPH-4 data confirmed: 12 mg retatrutide produced 23.7% weight loss, translating to an average of 60 pounds lost
It did not provide a separate standardised assessment of an arginate material
The convenience of at-home administration combined with clinical-grade absorption makes this delivery method increasingly popular
Product Specifications Compound Type: Copper-binding tripeptide complex Classification: Regenerative signaling peptide Primary Structure: Glycyl-L-histidyl-L-lysine copper complex Molecular Formula: CHNOCu Molecular Weight: ~403.93 g/mol Administration Route: Subcutaneous or topical application observed in research settings Stability Profile: High stability copper-peptide complex Development Status: Advanced research phase Research Focus: Skin remodeling pathways, collagen support signaling, follicular research, antioxidant activity, and tissue recovery models Quality Commitment SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards
Lower NAD+ levels are also associated with repair enzymes like PARP1 and sirtuins becoming less effective, allowing DNA damage and cellular stress to accumulate[1]
Lancet Oncol 16(7):763774 Gianni L et al (2014) Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort
US$ 25.54
US$ 20.49
US$ 29.16
